• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于选择加入、选择退出或基于风险的检测方法的 HIV 检测接受率:系统评价和荟萃分析。

HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis.

机构信息

University of Melbourne, Melbourne, Australia.

Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia.

出版信息

Curr HIV/AIDS Rep. 2022 Oct;19(5):375-383. doi: 10.1007/s11904-022-00614-0. Epub 2022 Jul 13.

DOI:10.1007/s11904-022-00614-0
PMID:35829949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9508204/
Abstract

PURPOSE OF REVIEW

Improving HIV testing uptake is essential to ending the HIV pandemic. HIV testing approaches can be opt-in, opt-out or risk-based. This systematic review examines and compares the uptake of HIV testing in opt-in, opt-out and risk-based testing approaches.

RECENT FINDINGS

There remain missed opportunities for HIV testing in a variety of settings using different approaches: opt-in (a person actively accepts to be tested for HIV), opt-out (a person is informed that HIV testing is routine/standard of care, and they actively decline if they do not wish to be tested for HIV) or risk-based (using risk-based screening tools to focus testing on certain individuals or sub-populations at greater risk of HIV). It is not clear how the approach could impact HIV test uptake when adjusted for other factors (e.g. rapid testing, country-income level, test setting and population tested). We searched four databases for studies reporting on HIV test uptake. In total, 18,238 records were screened, and 150 studies were included in the review. Most studies described an opt-in approach (87 estimates), followed by opt-out (76) and risk-based (19). Opt-out testing was associated with 64.3% test uptake (I = 99.9%), opt-in testing with 59.8% (I = 99.9%) and risk-based testing with 54.4% (I = 99.9%). When adjusted for settings that offered rapid testing, country income level, setting and population tested, opt-out testing had a significantly higher uptake (+ 12% (95% confidence intervals: 3-21), p = 0.007) than opt-in testing. We also found that emergency department patients and hospital outpatients had significantly lower HIV test uptake than other populations.

摘要

目的

提高 HIV 检测率对于终结 HIV 大流行至关重要。HIV 检测方法包括自愿检测、默认检测和基于风险的检测。本系统综述旨在评估并比较这三种检测方法对 HIV 检测率的影响。

最新发现

在不同的环境中,通过不同的方法,HIV 检测的机会仍然被错过:自愿检测(个人主动选择接受 HIV 检测)、默认检测(告知个人 HIV 检测是常规/标准护理,如果他们不想接受 HIV 检测,他们可以主动拒绝)或基于风险的检测(使用基于风险的筛查工具,将检测集中在具有较高 HIV 风险的特定个体或亚人群上)。目前尚不清楚在调整其他因素(例如快速检测、国家收入水平、检测环境和检测人群)后,该方法如何影响 HIV 检测率。我们在四个数据库中检索了报告 HIV 检测率的研究。共筛选出 18238 条记录,纳入了 150 项研究。大多数研究描述了自愿检测方法(87 项评估),其次是默认检测(76 项)和基于风险的检测(19 项)。默认检测的检测率为 64.3%(I=99.9%),自愿检测的检测率为 59.8%(I=99.9%),基于风险的检测的检测率为 54.4%(I=99.9%)。当调整了提供快速检测的环境、国家收入水平、检测环境和检测人群后,默认检测的检测率明显高于自愿检测(增加了 12%(95%置信区间:3-21),p=0.007)。我们还发现,急诊科患者和医院门诊患者的 HIV 检测率明显低于其他人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6908/9508204/ff76278f2d79/11904_2022_614_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6908/9508204/9b2a4cfe330a/11904_2022_614_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6908/9508204/ff76278f2d79/11904_2022_614_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6908/9508204/9b2a4cfe330a/11904_2022_614_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6908/9508204/ff76278f2d79/11904_2022_614_Fig2_HTML.jpg

相似文献

1
HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis.基于选择加入、选择退出或基于风险的检测方法的 HIV 检测接受率:系统评价和荟萃分析。
Curr HIV/AIDS Rep. 2022 Oct;19(5):375-383. doi: 10.1007/s11904-022-00614-0. Epub 2022 Jul 13.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
4
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Strategies to improve smoking cessation rates in primary care.提高初级保健中戒烟率的策略。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

引用本文的文献

1
Frequent Missed Opportunities for Earlier HIV Diagnosis in a Routine Opt-out Testing Environment in Atlanta.在亚特兰大常规的主动退出式检测环境中,早期HIV诊断存在频繁的错失机会。
Open Forum Infect Dis. 2025 Aug 26;12(8):ofaf423. doi: 10.1093/ofid/ofaf423. eCollection 2025 Aug.
2
Trend and Associated Factors for Late and Advanced HIV Diagnoses in 2011-2022 in Melbourne, Australia.2011 - 2022年澳大利亚墨尔本晚期和艾滋病晚期诊断的趋势及相关因素
J Med Virol. 2025 Jun;97(6):e70430. doi: 10.1002/jmv.70430.
3
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial.

本文引用的文献

1
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review.基于风险的筛查工具优化艾滋病毒检测服务:系统评价。
Curr HIV/AIDS Rep. 2022 Apr;19(2):154-165. doi: 10.1007/s11904-022-00601-5. Epub 2022 Feb 11.
2
Effect of an opt-out point-of-care HIV-1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomized controlled trial.一项在肯尼亚开展的随机对照试验表明,采用基于护理点的 HIV-1 核酸检测的“选择退出”策略,对有症状的成年门诊患者进行急性和现症 HIV 感染检测,可减少 HIV 传播:该策略可有效检测出急性和现症 HIV 感染,并降低 HIV 传播风险。
HIV Med. 2022 Jan;23(1):16-28. doi: 10.1111/hiv.13157. Epub 2021 Aug 25.
3
一项基于选择架构的干预措施对非洲南部艾滋病毒感染者结核病预防性治疗处方影响的评估(CAT研究):一项整群随机试验。
BMJ Glob Health. 2025 May 24;10(5):e016921. doi: 10.1136/bmjgh-2024-016921.
4
Attitudes of Japanese physicians not specializing in care toward people living with HIV and their care.日本非专科护理医生对艾滋病毒感染者及其护理的态度。
BMC Health Serv Res. 2025 May 14;25(1):693. doi: 10.1186/s12913-025-12842-2.
5
Development and calibration of a mathematical model of HIV outcomes among Rwandan adults: Informing achievement of global targets across sub-populations in Rwanda.卢旺达成年人中艾滋病毒感染结果数学模型的开发与校准:为卢旺达各亚人群实现全球目标提供信息。
PLoS One. 2025 May 14;20(5):e0310662. doi: 10.1371/journal.pone.0310662. eCollection 2025.
6
Postpandemic Trends and Missed Opportunities in Prevention and Diagnosis of Pediatric HIV.新冠疫情后儿童艾滋病预防与诊断的趋势及错失的机遇
Pediatr Infect Dis J. 2025 Apr 15;44(9):e312-e318. doi: 10.1097/INF.0000000000004822.
7
Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial.基层医疗诊所评估遗传性癌症风险的策略:一项整群随机临床试验。
JAMA Netw Open. 2025 Mar 3;8(3):e250185. doi: 10.1001/jamanetworkopen.2025.0185.
8
Choice-architecture TB preventive therapy prescribing for HIV patients in Mozambique.莫桑比克针对艾滋病毒患者的选择架构式结核病预防性治疗处方
Public Health Action. 2025 Mar 1;15(1):21-25. doi: 10.5588/pha.24.0033. eCollection 2025 Mar.
9
Missed and Delayed Diagnoses of Acute Human Immunodeficiency Virus (HIV) Infection in a Southern Opt-Out HIV Testing Environment Without Reflex HIV RNA Testing.在一个不进行反射性HIV RNA检测的南方选择退出式HIV检测环境中,急性人类免疫缺陷病毒(HIV)感染的漏诊和延迟诊断情况。
Open Forum Infect Dis. 2025 Jan 17;12(1):ofae684. doi: 10.1093/ofid/ofae684. eCollection 2025 Jan.
10
Facilitators and Barriers of Implementing Expanded Sexually Transmitted Infection Screening in California Family Planning Clinics.加利福尼亚州计划生育诊所实施扩大性传播感染筛查的促进因素与障碍
Sex Transm Dis. 2025 Jan 1;52(1):9-13. doi: 10.1097/OLQ.0000000000002072. Epub 2024 Sep 27.
Designing HIV Testing and Self-Testing Services for Young People in Nigeria: A Discrete Choice Experiment.
为尼日利亚年轻人设计艾滋病毒检测和自我检测服务:离散选择实验。
Patient. 2021 Nov;14(6):815-826. doi: 10.1007/s40271-021-00522-2. Epub 2021 May 4.
4
Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies.解决社区药房中艾滋病毒即时检测的障碍
Pharmacy (Basel). 2021 Apr 16;9(2):84. doi: 10.3390/pharmacy9020084.
5
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
PLoS Med. 2021 Mar 29;18(3):e1003583. doi: 10.1371/journal.pmed.1003583. eCollection 2021 Mar.
6
Heterogeneity in individual preferences for HIV testing: A systematic literature review of discrete choice experiments.个体对HIV检测偏好的异质性:离散选择实验的系统文献综述
EClinicalMedicine. 2020 Nov 30;29-30:100653. doi: 10.1016/j.eclinm.2020.100653. eCollection 2020 Dec.
7
Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016.估算 2010-2016 年期间欧洲 HIV 晚期发病及其可归因发病率和死亡率的负担。
BMC Infect Dis. 2020 Oct 7;20(1):728. doi: 10.1186/s12879-020-05261-7.
8
Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.治疗即预防:降低艾滋病毒感染率的概念与挑战
J Acquir Immune Defic Syndr. 2019 Dec 1;82 Suppl 2(2):S104-S112. doi: 10.1097/QAI.0000000000002168.
9
Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.HIV 感染预防的暴露前预防:美国预防服务工作组的证据报告和系统评价。
JAMA. 2019 Jun 11;321(22):2214-2230. doi: 10.1001/jama.2019.2591.
10
Pharmacists in HIV Prevention: An Untapped Potential.药剂师在艾滋病预防中的作用:未被发掘的潜力。
Am J Public Health. 2019 Jun;109(6):859-861. doi: 10.2105/AJPH.2019.305057.